(+/-)-3--甲基谷氨酸
(+/-)-3--甲基谷氨酸结构式
|
常用名 | (+/-)-3--甲基谷氨酸 | 英文名 | (±)-threo-3-Methylglutamic acid |
|---|---|---|---|---|
| CAS号 | 63088-04-0 | 分子量 | 161.15600 | |
| 密度 | 1.329g/cm3 | 沸点 | 329.4ºC at 760 mmHg | |
| 分子式 | C6H11NO4 | 熔点 | N/A | |
| MSDS | 中文版 美版 | 闪点 | 153ºC | |
| 符号 |
GHS07 |
信号词 | Warning |
|
Guide to Receptors and Channels (GRAC), 4th Edition.
Br. J. Pharmacol. 158 Suppl 1 , S1-254, (2009)
|
|
|
In vitro comparison of the effect of inhalation delay and flow rate on the emitted dose from three valved holding chambers.
J. Aerosol Med. Pulm. Drug Deliv. 27 Suppl 1 , S37-43, (2014) Valved holding chambers (VHCs) are accessory devices for pressurized metered dose inhalers (pMDIs). Use of a VHC may help overcome coordination issues associated with drug delivery via the pMDI alone. Previous work has established that aspects of VHC use, inc... |
期刊文献综述：
更多...